Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ABUS | Arbutus Biopharma Corp | Chief Financial Officer | $421K | -$22.2K | -5.01% | Feb 1, 2024 |
SCYX | SCYNEXIS INC | Director | $75.3K | Jun 20, 2024 | ||
ETTX | Entasis Therapeutics Holdings Inc. | Director | Jul 7, 2022 | |||
NTBL | Notable Labs, Ltd. | Director | Jan 1, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|